Comparative Pharmacology
Head-to-head clinical analysis: JUNIOR STRENGTH ADVIL versus MOTRIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: JUNIOR STRENGTH ADVIL versus MOTRIN.
JUNIOR STRENGTH ADVIL vs MOTRIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Non-selective cyclooxygenase (COX-1 and COX-2) inhibition, reducing prostaglandin synthesis, thereby decreasing inflammation, pain, and fever.
Non-selective COX-1 and COX-2 inhibitor, reducing prostaglandin synthesis.
200-400 mg orally every 4-6 hours as needed; maximum 1200 mg/day for OTC use.
Ibuprofen (Motrin) 200-800 mg orally every 6-8 hours as needed; maximum 3200 mg/day for acute pain, and 2400 mg/day for chronic use.
None Documented
None Documented
2-4 hours (terminal); prolonged in hepatic impairment and elderly.
Terminal elimination half-life approximately 2-4 hours in adults with normal renal function; prolonged in elderly and patients with renal impairment (up to 6-8 hours). No significant accumulation occurs with regular dosing.
Primarily renal (90% as glucuronide conjugates and 10% unchanged); <5% biliary/fecal.
Renal excretion of conjugated metabolites (approximately 70-80% as glucuronide and sulfate conjugates); less than 10% excreted unchanged. Biliary/fecal elimination accounts for about 10-20%.
Category C
Category C
NSAID Analgesic
NSAID Analgesic